Wednesday, February 10, 2010, 4:27am EST - Canadian Markets open in 5 hours and 3 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Auxilium Pharmaceuticals Inc. (AUXL)

 On Feb 9: 30.97 USD   0.00 (0.00%)  
MORE ON AUXL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Auxilium Pharmaceuticals, Inc. (NasdaqNM:AUXL) Delayed quote dataEdit
Last Trade: 30.97 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 30.97
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 35.71
Day's Range: N/A - N/A
52wk Range: 21.85 - 37.28
Volume: 0
Avg Vol (3m): 619,335
Market Cap: 1.46B
P/E (ttm): N/A
EPS (ttm): -1.27
Div & Yield: N/A (N/A%)
Auxilium Pharmaceuticals Inc. (AUXL)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add AUXL to Portfolio   Download Data

HEADLINES
• Auxillium shares fall on Xiaflex note
AP (Thu, Feb 4)
• Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010
Marketwire (Thu, Feb 4)
• [$$] Small Caps Sink as Earnings Drag on Financials
at The Wall Street Journal Online (Wed, Feb 3)
• Auxilium's New Hand Drug Jives With Investors
at Forbes.com (Wed, Feb 3)
• Toyota, Pfizer, Western Union are big movers
AP (Wed, Feb 3)
• Auxilium Gets The Go-Ahead On New Drug
at Forbes.com (Wed, Feb 3)
• FDA Approves Auxilium's Xiaflex
Zacks.com (Wed, Feb 3)
• Auxilium’s Xiaflex treatment for hand disease approved by FDA
at bizjournals.com (Wed, Feb 3)
• Auxilium says FDA approved hand drug Xiaflex
AP (Wed, Feb 3)
• Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
PRNewswire (Wed, Feb 3)
• AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exh
EDGAR Online (Wed, Feb 3)
More Headlines for AUXL...
ANALYST
EPS Est (next year) (Dec-09) : -1.29
EPS Est (in 2 years) (Dec-10) : -0.62
Avg Rec (current)*: 2.1
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and primary care physicians primarily in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices